Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Orthobiologics Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
    5.1. Key Market Trends
    5.2. Merger & Acquisition
    5.3. Strategies of Top Five Players Operating in the Market
    5.4. Incidence of Orthopedic Disorder, by Key Countries
    5.5. Number of Surgical Procedures
    5.6. Regulatory and Reimbursement Scenario by Key Countries
    5.7. Covid-19 Pandemic Impact on the Industry

6. Global Orthobiologics Market Analysis and Forecast, by Product
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product, 2017-2031
        6.3.1. Allografts
        6.3.2. Xenografts
        6.3.3. Synthetic Bone Grafts
            6.3.3.1. Hydroxyapatite
            6.3.3.2. ?-tricalcium Phosphate (?-TCP)
            6.3.3.3. BiPhasic
            6.3.3.4. Bioactive Glass
            6.3.3.5. Others
        6.3.4. Demineralized Bone Matrix (DBM)
        6.3.5. Viscosupplementation
        6.3.6. Platelet-rich Plasma (PRP)
        6.3.7. Bone Marrow Aspirate Concentrate (BMAC)
        6.3.8. Others
    6.4. Market Attractiveness Analysis, by Product

7. Global Orthobiologics Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Application, 2017-2031
        7.3.1. Spinal Fusion
        7.3.2. Trauma Repair
        7.3.3. Reconstructive Surgeries
        7.3.4. Fractures
        7.3.5. Osteoarthritis
        7.3.6. Maxillofacial & Dental Applications
        7.3.7. Others
    7.4. Market Attractiveness Analysis, by Application

8. Global Orthobiologics Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by End-user, 2017-2031
        8.3.1. Hospitals
        8.3.2. Orthopedic Clinics
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by End-user

9. Global Orthobiologics Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region

10. North America Orthobiologics Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product, 2017-2031
        10.2.1. Allografts
        10.2.2. Xenografts
        10.2.3. Synthetic Bone Grafts
            10.2.3.1. Hydroxyapatite
            10.2.3.2. ?-tricalcium Phosphate (?-TCP)
            10.2.3.3. BiPhasic
            10.2.3.4. Bioactive Glass
            10.2.3.5. Others
        10.2.4. Demineralized Bone Matrix (DBM)
        10.2.5. Viscosupplementation
        10.2.6. Platelet-rich Plasma (PRP)
        10.2.7. Bone Marrow Aspirate Concentrate (BMAC)
        10.2.8. Others
    10.3. Market Value Forecast, by Application, 2017-2031
        10.3.1. Spinal Fusion
        10.3.2. Trauma Repair
        10.3.3. Reconstructive Surgeries
        10.3.4. Fractures
        10.3.5. Osteoarthritis
        10.3.6. Maxillofacial & Dental Applications
        10.3.7. Others
    10.4. Market Value Forecast, by End-user, 2017-2031
        10.4.1. Hospitals
        10.4.2. Orthopedic Clinics
        10.4.3. Others
    10.5. Market Value Forecast, by Country, 2017-2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country

11. Europe Orthobiologics Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product, 2017-2031
        11.2.1. Allografts
        11.2.2. Xenografts
        11.2.3. Synthetic Bone Grafts
            11.2.3.1. Hydroxyapatite
            11.2.3.2. ?-tricalcium Phosphate (?-TCP)
            11.2.3.3. BiPhasic
            11.2.3.4. Bioactive Glass
            11.2.3.5. Others
        11.2.4. Demineralized Bone Matrix (DBM)
        11.2.5. Viscosupplementation
        11.2.6. Platelet-rich Plasma (PRP)
        11.2.7. Bone Marrow Aspirate Concentrate (BMAC)
        11.2.8. Others
    11.3. Market Value Forecast, by Application, 2017-2031
        11.3.1. Spinal Fusion
        11.3.2. Trauma Repair
        11.3.3. Reconstructive Surgeries
        11.3.4. Fractures
        11.3.5. Osteoarthritis
        11.3.6. Maxillofacial & Dental Applications
        11.3.7. Others
    11.4. Market Value Forecast, by End-user, 2017-2031
        11.4.1. Hospitals
        11.4.2. Orthopedic Clinics
        11.4.3. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Orthobiologics Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product, 2017-2031
        12.2.1. Allografts
        12.2.2. Xenografts
        12.2.3. Synthetic Bone Grafts
            12.2.3.1. Hydroxyapatite
            12.2.3.2. ?-tricalcium Phosphate (?-TCP)
            12.2.3.3. BiPhasic
            12.2.3.4. Bioactive Glass
            12.2.3.5. Others
        12.2.4. Demineralized Bone Matrix (DBM)
        12.2.5. Viscosupplementation
        12.2.6. Platelet-rich Plasma (PRP)
        12.2.7. Bone Marrow Aspirate Concentrate (BMAC)
        12.2.8. Others
    12.3. Market Value Forecast, by Application, 2017-2031
        12.3.1. Spinal Fusion
        12.3.2. Trauma Repair
        12.3.3. Reconstructive Surgeries
        12.3.4. Fractures
        12.3.5. Osteoarthritis
        12.3.6. Maxillofacial & Dental Applications
        12.3.7. Others
    12.4. Market Value Forecast, by End-user, 2017-2031
        12.4.1. Hospitals
        12.4.2. Orthopedic Clinics
        12.4.3. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Orthobiologics Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product, 2017-2031
        13.2.1. Allografts
        13.2.2. Xenografts
        13.2.3. Synthetic Bone Grafts
            13.2.3.1. Hydroxyapatite
            13.2.3.2. ?-tricalcium Phosphate (?-TCP)
            13.2.3.3. BiPhasic
            13.2.3.4. Bioactive Glass
            13.2.3.5. Others
        13.2.4. Demineralized Bone Matrix (DBM)
        13.2.5. Viscosupplementation
        13.2.6. Platelet-rich Plasma (PRP)
        13.2.7. Bone Marrow Aspirate Concentrate (BMAC)
        13.2.8. Others
    13.3. Market Value Forecast, by Application, 2017-2031
        13.3.1. Spinal Fusion
        13.3.2. Trauma Repair
        13.3.3. Reconstructive Surgeries
        13.3.4. Fractures
        13.3.5. Osteoarthritis
        13.3.6. Maxillofacial & Dental Applications
        13.3.7. Others
    13.4. Market Value Forecast, by End-user, 2017-2031
        13.4.1. Hospitals
        13.4.2. Orthopedic Clinics
        13.4.3. Others
    13.5. Market Value Forecast, by Country, 2017-2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country/Sub-region

14. Middle East & Africa Orthobiologics Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product, 2017-2031
        14.2.1. Allografts
        14.2.2. Xenografts
        14.2.3. Synthetic Bone Grafts
            14.2.3.1. Hydroxyapatite
            14.2.3.2. ?-tricalcium Phosphate (?-TCP)
            14.2.3.3. BiPhasic
            14.2.3.4. Bioactive Glass
            14.2.3.5. Others
        14.2.4. Demineralized Bone Matrix (DBM)
        14.2.5. Viscosupplementation
        14.2.6. Platelet-rich Plasma (PRP)
        14.2.7. Bone Marrow Aspirate Concentrate (BMAC)
        14.2.8. Others
    14.3. Market Value Forecast, by Application, 2017-2031
        14.3.1. Spinal Fusion
        14.3.2. Trauma Repair
        14.3.3. Reconstructive Surgeries
        14.3.4. Fractures
        14.3.5. Osteoarthritis
        14.3.6. Maxillofacial & Dental Applications
        14.3.7. Others
    14.4. Market Value Forecast, by End-user, 2017-2031
        14.4.1. Hospitals
        14.4.2. Orthopedic Clinics
        14.4.3. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country/Sub-region

15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share/Ranking Analysis, by Company, 2022
    15.3. Company Profiles
        15.3.1. Alphatec Spine, Inc.
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Strategic Overview
        15.3.2. Arthrex
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Strategic Overview
        15.3.3. Bioventus LLC
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Strategic Overview
        15.3.4. Exactech, Inc.
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Strategic Overview
        15.3.5. Global Medical, Inc.
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Strategic Overview
        15.3.6. Integra Lifesciences
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Strategic Overview
        15.3.7. Medtronic
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Strategic Overview
        15.3.8. MTF Biologics
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Strategic Overview
        15.3.9. RTI Surgical
            15.3.9.1. Company Overview
            15.3.9.2. Product Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Strategic Overview
        15.3.10. Sano Orthopedics
            15.3.10.1. Company Overview
            15.3.10.2. Product Portfolio
            15.3.10.3. SWOT Analysis
            15.3.10.4. Strategic Overview
        15.3.11. Sanofi
            15.3.11.1. Company Overview
            15.3.11.2. Product Portfolio
            15.3.11.3. SWOT Analysis
            15.3.11.4. Strategic Overview
        15.3.12. Seikagaku Corporation
            15.3.12.1. Company Overview
            15.3.12.2. Product Portfolio
            15.3.12.3. SWOT Analysis
            15.3.12.4. Strategic Overview
        15.3.13. Stryker
            15.3.13.1. Company Overview
            15.3.13.2. Product Portfolio
            15.3.13.3. SWOT Analysis
            15.3.13.4. Strategic Overview
        15.3.14. Zimmer Biomet
            15.3.14.1. Company Overview
            15.3.14.2. Product Portfolio
            15.3.14.3. SWOT Analysis
            15.3.14.4. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Orthobiologics Market Value Share, by Product, 2021

Figure 03: Global Orthobiologics Market Value Share, by Application, 2021

Figure 04: Global Orthobiologics Market Value Share, by End-user, 2021

Figure 05: Global Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

Figure 06: Global Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

Figure 07: Global Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

Figure 08: Global Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

Figure 09: Global Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

Figure 10: Global Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 11: Global Orthobiologics Market Value Share Analysis, by Region, 2021 and 2031

Figure 12: Global Orthobiologics Market Attractiveness Analysis, by Region, 2023–2031

Figure 13: North America Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

Figure 14: North America Orthobiologics Market Value Share Analysis, by Country, 2021 and 2031

Figure 15: North America Orthobiologics Market Attractiveness Analysis, by Country, 2023–2031?

Figure 16: North America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

Figure 17: North America Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

Figure 18: North America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

Figure 19: North America Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

Figure 20: North America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

Figure 21: North America Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 22: Europe Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

Figure 23: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 24: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 25: Europe Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

Figure 26: Europe Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

Figure 27: Europe Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

Figure 28: Europe Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

Figure 29: Europe Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

Figure 30: Europe Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 31: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

Figure 32: Asia Pacific Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 33: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 34: Asia Pacific Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

Figure 35: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

Figure 36: Asia Pacific Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

Figure 37: Asia Pacific Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

Figure 38: Asia Pacific Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

Figure 39: Asia Pacific Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 40: Latin America Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

Figure 41: Latin America Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 42: Latin America Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031

Figure 43: Latin America Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

Figure 44: Latin America Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

Figure 45: Latin America Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

Figure 46: Latin America Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

Figure 47: Latin America Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

Figure 48: Latin America Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 49: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031

Figure 50: Middle East & Africa Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 51: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2021-2031

Figure 52: Middle East & Africa Orthobiologics Market Value Share Analysis, by Product, 2021 and 2031

Figure 53: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Product, 2023–2031

Figure 54: Middle East & Africa Orthobiologics Market Value Share Analysis, by Application, 2021 and 2031

Figure 55: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Application, 2023–2031

Figure 56: Middle East & Africa Orthobiologics Market Value Share Analysis, by End-user, 2021 and 2031

Figure 57: Middle East & Africa Orthobiologics Market Attractiveness Analysis, by End-user, 2023–2031

Figure 58: Company Share Analysis, 2021

List of Tables

List of Tables

Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017?2031

Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by 2017?2031, by Application

Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Orthobiologics Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017?2031

Table 07: North America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017?2031

Table 08: North America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017?2031

Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017?2031

Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017?2031

Table 15: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017?2031

Table 16: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 18: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017?2031

Table 19: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017?2031

Table 20: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 22: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017?2031

Table 23: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017?2031

Table 24: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031